The Trump administration has reached an agreement with researchers and Democratic-led states who filed a lawsuit over cuts to diversity-related research funding at the National Institutes of Health (NIH). The deal, announced Monday, allows stalled or rejected grant applications to move forward for review after months of legal uncertainty surrounding diversity, equity, and inclusion (DEI) research funding.
The dispute began after the NIH canceled hundreds of millions of dollars in research grants, citing concerns that the projects were tied to DEI initiatives rather than core scientific objectives. In response, affected researchers and states sued the federal government, arguing that the funding cuts were unlawful and arbitrary. Earlier this year, U.S. District Judge William Young ruled in Boston that the NIH had improperly terminated the grants, finding that the cancellations violated federal law.
However, the legal battle became more complex in August when the U.S. Supreme Court partially paused Judge Young’s ruling. The high court determined that claims related to the terminated grants should be heard by a specialized federal court that handles monetary disputes with the government. At the same time, the Supreme Court left unresolved a separate issue regarding how the NIH handled applications for future research funding.
Monday’s agreement addresses that unresolved portion of the case. Under the deal, the federal government has agreed to conduct new reviews of grant applications that were frozen, denied, or withdrawn after the policy change was announced. Importantly, the agreement does not require the NIH to approve or fund any specific research proposals, but it does reopen the door for fair consideration.
The researchers involved say the affected grants cover critical public health areas, including HIV prevention, Alzheimer’s disease, LGBTQ health, and sexual violence research. One of the plaintiffs, Nikki Maphis, a postdoctoral researcher at the University of New Mexico, welcomed the development, saying it allows her Alzheimer’s and aging brain research to move forward after what she described as an “arbitrary and destructive freeze.”
The agreement does not affect Judge Young’s earlier ruling blocking the NIH policy itself. The U.S. Department of Health and Human Services has appealed that decision and maintains that it ended funding for research it believes prioritized ideology over scientific rigor.


Senate Majority Leader John Thune Moves to Advance Crypto Clarity Act
Trump Administration Weighs Executive Order on Vaccines and Autism Research
Russia Intensifies Drone and Bomb Attacks on Ukraine’s Zaporizhzhia, Deepening Civilian Fear
California ICE Detention Center Found to Have Inadequate Medical Care, Court Monitor Says
Paramount-Warner Bros. Merger Delayed Until 2027 Amid Antitrust Lawsuit
25 Democratic-Led States Sue Trump Administration Over New Global Tariffs
Trump Election Order Blocked Again as Appeals Court Rejects Mail-In Voting Push in 23 States
Eduardo Bolsonaro Granted U.S. Green Card Amid Brazil Legal Battle and Tariff Dispute
U.S. Unseals Charges Against Five Alleged CJNG Leaders, Raises Reward for New Cartel Chief
Joe Biden’s Prostate Cancer Has Spread Further, Hunter Biden Says
Trump Faces Tough Choices as Iran War Drags On
New Mexico Sues DOJ Over Unredacted Jeffrey Epstein Files Amid Ongoing Investigation
Brazil Supreme Court Tightens Jair Bolsonaro House Arrest Ahead of Election
Juan Orlando Hernandez Seeks Dismissal of Honduras Charges After Trump Pardon
Taiwan President Lai Oversees Coastal Strike Drills in Han Kuang War Games
Trump Orders Probe Into Pentagon Munitions Stockpile Leaks After Iran Conflict
India Plans Tax Reforms to Boost Foreign Investment and Manufacturing 



